# A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

> **NCT05907044** · NA · COMPLETED · sponsor: **Affiliated Hospital of Yunnan University** · enrollment: 376 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** RQ3013
- **BIOLOGICAL:** RQ3025
- **BIOLOGICAL:** RQ3027

## Key facts

- **NCT ID:** NCT05907044
- **Lead sponsor:** Affiliated Hospital of Yunnan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-08
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-11-23
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05907044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05907044, "A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05907044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*